Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

慢性B型肝炎に対するインターフェロン療法

W Weimar, H Schellekens

    Lancet (London, England)
    |March 15, 1980
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Interferon Beta: From Molecular Level to Therapeutic Effects.

    International review of cell and molecular biology·2016
    Same author

    The value of non-human primates in the development of monoclonal antibodies.

    Nature biotechnology·2013
    Same author

    The risk-based approach to ATMP development - generally accepted by regulators but infrequently used by companies.

    Regulatory toxicology and pharmacology : RTP·2013
    Same author

    The cost-effectiveness of periodic safety update reports for biologicals in Europe.

    Clinical pharmacology and therapeutics·2013
    Same author

    A framework for improving the quality of care for people with psoriasis.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2012
    Same author

    The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies.

    Clinical pharmacology and therapeutics·2011
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る